CA Stock MarketDetailed Quotes

GUD Knight Therapeutics Inc

Watchlist
  • 5.480
  • +0.080+1.48%
15min DelayMarket Closed Jan 17 16:00 ET
552.40MMarket Cap-18.90P/E (TTM)

Knight Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Knight Therapeutics Inc Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 86.450M--
--2024/Q4-- / 87.621M--
Nov 7, 20242024/Q392.263M / 89.426M--
Aug 8, 20242024/Q295.573M / 87.667M--
May 9, 20242024/Q186.604M / 79.499M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 86.450M--
--2024/Q4-- / 87.621M--
Nov 7, 20242024/Q392.263M / 89.426M--
Aug 8, 20242024/Q295.573M / 87.667M--
May 9, 20242024/Q186.604M / 79.499M--

Unlock Free Earnings Estimates

Knight Therapeutics Inc Earnings Reports

  • Knight Therapeutics Inc: INTERIM MDA FR

    Nov 8, 2024 16:48 ET

  • Knight Therapeutics Inc: INTERIM FINANCIAL STATEMENTSREPORT FR

    Nov 8, 2024 16:45 ET

  • Knight Therapeutics Inc: INTERIM MDA EN

    Nov 7, 2024 07:39 ET

  • Knight Therapeutics Inc: INTERIM FINANCIAL STATEMENTSREPORT EN

    Nov 7, 2024 07:39 ET

    • Read more

    Heat List
    CA
    Overall
    Symbol
    Price
    % Chg

    No Data